echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JNNP: Will the new coronavirus infection increase the risk of anxiety or depression infection?

    JNNP: Will the new coronavirus infection increase the risk of anxiety or depression infection?

    • Last Update: 2021-10-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Previous studies of the new coronavirus have shown that the risk of neurological diseases is increased, and anxiety/depressive symptoms may be more common in individuals after SARS-CoV-2 infection


    To quantify the relationship between SARS-CoV-2 infection and anxiety/depressive symptoms themselves, it is necessary to separate the consequences of infection from other factors


    This study used a large community cohort to assess the prevalence of anxiety/depressive symptoms in individuals with or without SARS-CoV-2 infection


    This article was published in the " Journal of Neurology, Neurosurgery & Psychiatry " ( Journal of Neurology, Neurosurgery & Psychiatry )


    The survey data is obtained by the Coronavirus Symptom Research App, a mobile app developed by the health data company Zoe Limited in collaboration with King's College London (KCL), Massachusetts General Hospital, Lund University and Uppsala University


    When registering, app users provide demographic and clinical data, including age, height, weight, gender, other diseases (i.


    Between February 23, 2021 and April 12, 2021, app contributors are invited to answer a survey on their mental health


    The age, gender, body mass index (BMI) group (underweight, overweight, obesity, normal BMI (18.


    421977 non-medical workers (aged 18-99, body mass index 15-55) responded to the mental health survey, and 35,827 were positive


    Correlation between age, body mass index, comorbidities, learning disabilities, positive SARS-CoV-2 test results and anxiety/depressive symptoms

    In general, SARS-CoV-2 infection is associated with anxiety/depressive symptoms


    SARS-CoV-2 infection is associated with anxiety/depressive symptoms.


    Participant characteristics

    In this large community-based study, a positive correlation between SARS-CoV-2 infection and anxiety/depressive symptoms was reported


    No association was found between SARS-CoV-2 infection and anxiety/depressive symptoms in the young group (<40 years old)


    This suggests that the impact of SARS-CoV-2 on mental health may only be short-lived




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.